Evaluation of the Hospital Readmissions Reduction Program
暂无分享,去创建一个
[1] S. Normand,et al. Isolating Effects of Medicare Code Slot Expansion on Longitudinal Risk Assessment , 2019 .
[2] H. Krumholz,et al. Evaluation of 30-Day Hospital Readmission and Mortality Rates Using Regression-Discontinuity Framework. , 2019, Journal of the American College of Cardiology.
[3] A. Jha,et al. Assessment of Strategies for Managing Expansion of Diagnosis Coding Using Risk-Adjustment Methods for Medicare Data. , 2019, JAMA internal medicine.
[4] R. Yeh,et al. The Hospital Readmissions Reduction Program - Time for a Reboot. , 2019, The New England journal of medicine.
[5] N. Sood,et al. Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program , 2019, JAMA network open.
[6] P. Heidenreich,et al. Comparison of the change in heart failure readmission and mortality rates between hospitals subject to hospital readmission reduction program penalties and critical access hospitals , 2019, American heart journal.
[7] Leemore S. Dafny,et al. Decreases In Readmissions Credited To Medicare's Program To Reduce Hospital Readmissions Have Been Overstated. , 2019, Health affairs.
[8] S. Haneuse,et al. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia , 2018, JAMA.
[9] G. Fonarow. Unintended Harm Associated With the Hospital Readmissions Reduction Program. , 2018, JAMA.
[10] H. Krumholz,et al. Effects of the Hospital Readmissions Reduction Program. , 2018, Circulation. Cardiovascular quality and outcomes.
[11] N. Sood,et al. HF Mortality Trends Under Medicare Readmissions Reduction Program at Penalized and Nonpenalized Hospitals. , 2018, Journal of the American College of Cardiology.
[12] S. Normand,et al. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia , 2018, JAMA network open.
[13] H. Krumholz,et al. Rising Mortality in Patients With Heart Failure in the United States: Facts Versus Fiction. , 2018, JACC. Heart failure.
[14] Leora I. Horwitz,et al. Publicly Reported Readmission Measures and the Hospital Readmissions Reduction Program: A False Equivalence? , 2018, Annals of Internal Medicine.
[15] S. Normand,et al. Evaluating Readmission-Need for More Clarity on Methods. , 2018, JAMA cardiology.
[16] Deepak L. Bhatt,et al. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure , 2017, JAMA cardiology.
[17] Leora I. Horwitz,et al. Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge , 2017, JAMA.
[18] A. Gasparrini,et al. Interrupted time series regression for the evaluation of public health interventions: a tutorial , 2016, International journal of epidemiology.
[19] Leora I. Horwitz,et al. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions. , 2016, JAMA.
[20] D. Himmelstein,et al. The Hospital Readmissions Reduction Program. , 2016, The New England journal of medicine.
[21] Leora I. Horwitz,et al. Development and Use of an Administrative Claims Measure for Profiling Hospital-wide Performance on 30-Day Unplanned Readmission , 2014, Annals of Internal Medicine.
[22] J. Thorpe,et al. Medicare Hospital Readmissions Reduction Program , 2011 .
[23] N M Thompson,et al. Analysis of change: modeling individual growth. , 1991, Journal of consulting and clinical psychology.